Skip to content
The Nexus
DossierENTITY

weight-loss drug market

Coverage of weight-loss drug market in the Nexus archive.

Earliest in view: Jun 16 · 09:21 UTCMost recent: Jul 21 · 23:01 UTC
Co-mentioned in this coverage
Eli Lillyorganization2Novo Nordiskorganization1Hims & Hersorganization1Wegovyproduct1prescription-only medicationstopic1disease awareness campaignstopic1Mounjarotopic1Brazilplace1
Recent coverage
  • BUSINESSJul 21 · 23:01 UTCSEMAFOR
    Novo sues Lilly amid escalating weight-loss rivalry

    Novo Nordisk sued Eli Lilly for misleading advertising in the US weight-loss drug market, alleging outdated weight-loss comparisons. Novo also previously sued Hims & Hers over a copycat version of Wegovy. The dispute highlights differences in global advertising regulations, as most countries prohibit ads for prescription-only medications.

  • BUSINESSJun 16 · 09:21 UTCTHE RIO TIMES
    Brazil’s Weight-Loss Drug Market Enters a Price War

    Eli Lilly reduced the price of its weight-loss drug Mounjaro in Brazil by up to 36% through a loyalty program, with starter packs dropping from R$3,350 to R$2,250. Some drug combinations saw price cuts exceeding R$2,000, triggering a price war in Brazil's weight-loss drug market.